Sjukvård | Njur | Dialys - Fresenius Medical Care
Transcript of Sjukvård | Njur | Dialys - Fresenius Medical Care
Acute Therapy Systems
Product Range
Continuous renal replacement therapy Multifunctional and easy to use
Fresenius Medical Care has always focused on
services for people.
We concentrate on the patients’ health as well as
the staff in the clinics.
In this brochure you will find a comprehensive
product range for acute renal replacement and
plasma therapy. These disposables and solutions
from Fresenius Medical Care have been specially
developed for the use in life-threatening situations.
In combination with the multiFiltrate the disposables
and solutions provide effective and safe treatments for
patients. The products are specially designed to com-
plement each other. As a result this enables nursing staff
to focus on patient care. In this brochure you will find
a number of benefits for patients, doctors and nurses.
Acute renal replacement therapy with
Fresenius Medical Care:
• Reliable
• Convenient
• Effective
3Technical changes reserved Product Range – 01. 2010
Contents
multiFiltrate acute therapy system ......................................................... 4
Complete kits for multiFiltrate ................................................................ 6
multiFiltrate: paediatric CRRT and SCUF ........................................... 10
CRRT haemofilters ............................................................................ 12
Plasmafilters ...................................................................................... 13
Solutions ........................................................................................... 14
Temporary dialysis catheters .............................................................. 20
Disposables and accessories ............................................................. 21
4 Product Range – 01. 2010 Technical changes reserved
multiFiltrateAcute therapy system
The setup of the tubing systems is clearly shown and
explained step by step on the screen of the multiFiltrate
Multifunctional and easy to use
Safe and easy handling is one of the main requirements
for a modern, multifunctional acute therapy system.
The multiFiltrate features an ergonomical and intuitive
operating concept with a wide range of renal replace-
ment therapies.
multiFiltrate acute therapy machine:
multiFiltrate basic Art. No. M20 070 1
with Ci-Ca module Art.-Nr. M20 127 1
5Technical changes reserved Product Range – 01. 2010
CVVHContinuous veno-venous haemofiltration
CVVHDContinuous veno-venous haemodialysis
CVVHDFContinuous veno-venous haemodiafiltration
Pre-Post CVVHPre-post continuous veno-venous haemofiltration (High volume)
paed CVVHPaediatric continuous veno-venous haemofiltration
paed CVVHDPaediatric continuous veno-venous haemodialysis
SCUFSlow continuous ultrafiltration
Range of therapies offered by the multiFiltrate acute therapy system
MPSMembrane plasma separation
HPHemoperfusion
Ci-Ca CVVHDContinuous veno-venous haemodialysis with citrate anticoagulation
6 Product Range – 01. 2010 Technical changes reserved
Complete kits for multiFiltrate
The multiFiltrate cassette – safe and easy
The multiFiltrate cassette consists of the arterial, venous
and filtrate lines. This allows easy installation of the tub-
ing systems required for each treatment. The combina-
tion of the multiFiltrate cassette with treatment specific
tubing systems enables the multiFiltrate to be set up
quickly, safely and easily.
multiFiltrate-Kit
The multiFiltrate-Kits contain:
• multiFiltrate cassette
(AV-set and filtrate system pre-assembled)
• Substituate and/or dialysate system
(depends on therapy modality)
• Haemofilter or plasmafilter
Kit guideline chart SCUF CVVH Pre-PostCVVH CVVHDF CVVHD Ci-CaCVVHD MPS HP paedCVVH paedCVVHD
5039011 multiFiltrateKitCi-CaCVVHD1000
5038871 multiFiltrateKit8CVVHDF1000
5038931 multiFiltrateKit4CVVHDF600
5038921 multiFiltrateKit3CVVHD600
5038181 multiFiltrateKit7HV-CVVH1000
5038791 multiFiltrateKit9CVVH1000
5038911 multiFiltrateKit2CVVH600
5038951 multiFiltrateKit6MPS2
5039051 multiFiltrateKitpaedCRRT/SCUF
= Dedicated usage, = Alternative usage
7Technical changes reserved Product Range – 01. 2010
Ci-Ca CVVHDContinuousveno-venoushaemo-dialysiswithcitrateanticoagulation
multiFiltrate – Kit Ci-Ca CVVHD 1000 Art. No. 503 901 1
Type Description
Ultraflux® AV 1000 S Ultraflux haemofilter, steam-sterilised, surface area 1.8 m2,
Fresenius High-Flux Polysulfone® membrane
multiFiltrate Ci-Ca Cassette multiFiltrate cassette with arterial and venous blood
tubing systems, filtrate system and integrated citrate
and calcium lines
Dialysate system Dialysate system for multiFiltrate with integrated
multiFiltrate heater bag
CVVHDFContinuousveno-venoushaemodiafiltration
multiFiltrate – Kit 8 CVVHDF 1000 Art. No. 503 887 1
Type Description
Ultraflux® AV 1000 S Ultraflux® haemofilter, steam-sterilised, 1.8 m2 surface
area, Fresenius Polysulfone® membrane
multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,
venous and filtrate system
Substituate System Substituate system for multiFiltrate with integrated
multiFiltrate heater bag
Dialysate System Dialysate system for multiFiltrate with integrated
multiFiltrate heater bag
multiFiltrate – Kit 4 CVVHDF 600 Art. No. 503 893 1
Type Description
Ultraflux® AV 600 S Ultraflux® haemofilter, steam-sterilised, 1.4 m2 surface
area, Fresenius Polysulfone® membrane
multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,
venous and filtrate system
Substituate System Substituate system for multiFiltrate with integrated
multiFiltrate heater bag
Dialysate System Dialysate system for multiFiltrate with integrated
multiFiltrate heater bag
8 Product Range – 01. 2010 Technical changes reserved
Complete kits for multiFiltrate
CVVHDContinuousveno-venoushaemodialysis
multiFiltrate – Kit 3 CVVHD 600 Art. No. 503 892 1
Type Description
Ultraflux® AV 600 S Ultraflux® haemofilter, steam-sterilised, 1.4 m2 surface
area, Fresenius Polysulfone® membrane
multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,
venous and filtrate system
Dialysate System Dialysate system for multiFiltrate with integrated
multiFiltrate heater bag
Pre-Post CVVHPre-postcontinuousveno-venoushaemofiltration(Highvolume)
multiFiltrate – Kit 7 HV-CVVH 1000 (High-Volume CVVH) Art. No. 503 818 1
Type Description
Ultraflux® AV 1000 S Ultraflux® haemofilter, steam-sterilised, 1.8 m2 surface
area, Fresenius Polysulfone® membrane
multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,
venous and filtrate system
HV-CVVH Substituate 2 substituate lines for multiFiltrate with integrated heater
Set multiFiltrate bags for pre- and postdilution
9Technical changes reserved Product Range – 01. 2010
multiFiltrate – Kit 6 MPS 2 (Membrane Plasma Separation) Art. No. 503 895 1
Type Description
plasmaFlux PSu 2S Plasmafilter pre-filled with sterile water, steam-sterilised
0.6 m2 surface area, Fresenius Plasmasulfone membrane
multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,
venous and filtrate system
MPS Substituate Substituate System for multiFiltrate with 2 integrated
System multiFiltrate heater bags, Luer-Lock male with 4 vented Spikes
pre-connected
Filtrate collection bag Filtrate collection bag, 10 L, with draining cock,
Luer-Lock connector male
MPSMembraneplasmaseparation
CVVHContinuousveno-venoushaemofiltration
multiFiltrate – Kit 9 CVVH 1000 Art. No. 503 879 1
Type Description
Ultraflux® AV 1000 S Ultraflux® haemofilter, steam-sterilised, 1.8 m2 surface
area, Fresenius Polysulfone® membrane
multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,
venous and filtrate system
Substituate System Substituate system for multiFiltrate with integrated
multiFiltrate heater bag
multiFiltrate – Kit 2 CVVH 600 Art. No. 503 891 1
Type Description
Ultraflux® AV 600 S Ultraflux® haemofilter, steam-sterilised, 1.4 m2 surface
area, Fresenius Polysulfone® membrane
multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,
venous and filtrate system
Substituate System Substituate system for multiFiltrate with integrated
multiFiltrate heater bag
10 Product Range – 01. 2010 Technical changes reserved
multiFiltrate: paediatric CRRT and SCUFSafe and efficient treatment of babies, infants and adults
A specifically developed multiFiltrate treatment-mode monitors the paediatric
therapy. The Ultraflux® AV paed haemofilter combined with special volume-
reduced lines is used to perform paediatric CVVH in post- or predilution
and CVVHD.
multiFiltrate Kit paed CRRT/SCUFmultiFiltrate – Kit paed CRRT/SCUF Art.-Nr. 503 905 1
Type Description
multiFiltrate paed AV-Set paed, blood volume 54 mL, filtrate system and
CRRT/SCUF Set dialysate/substituate system packed as a set
Ultraflux® AV paed Ultraflux® haemofilter, steam-sterilised,
surface area 0.2 m2 Fresenius High-Flux Polysulfone® membrane
Ultraflux® AV paed can only be used with holder for small dialysers (Art. No. M38 420 1) Total extracorporeal blood volume is only 72 mL (AV-Set 54 mL; Filter 18 mL)
Treatment parameters for paediatric treatment
Parameters
min. max. Increments Unit
Blood flow 10 100 2 mL/min
Ultrafiltration Off / 5 500 5 mL/h
UF goal Off /10 5000 10 mL
Cont. heparin adm. Off / 0.1 25 0.1 mL/h
Dialysate 100 1500 10 mL/h
Temperature Off / 35 39 0.5 °C
paed CVVHPaediatriccontinuousveno-venoushaemofiltration
paed CVVHDPaediatriccontinuousveno-venoushaemodialysis
11Technical changes reserved Product Range – 01. 2010
multiFiltrate Kit paed CRRT/SCUFmultiFiltrate – Kit paed CRRT/SCUF Art.-Nr. 503 905 1
Type Description
multiFiltrate paed AV-Set paed, blood volume 54 mL, filtrate system and
CRRT/SCUF Set dialysate/substituate system packed as a set
Ultraflux® AV paed Ultraflux® haemofilter, steam-sterilised,
surface area 0.2 m2 Fresenius High-Flux Polysulfone® membrane
Ultraflux® AV paed can only be used with holder for small dialysers (Art. No. M38 420 1) Total extracorporeal blood volume is only 72 mL (AV-Set 54 mL; Filter 18 mL)
The combination of the Ultraflux® AV paed haemofilter and the volume-
reduced lines enables the user to perform an efficient continuous ultrafil-
tration for adult and paediatric patients.
Treatment parameters for SCUF treatment
Parameters
min. max. Increments Unit
Blood flow 10 100 2 mL/min
Ultrafiltration Off / 10 1200 10 mL/h
UF goal Off /50 10000 50 mL
Cont. heparin adm. Off / 0.1 25 0.1 mL/h
SCUFSlowcontinuousultrafiltration
12 Product Range – 01. 2010 Technical changes reserved
CRRT haemofiltersUltraflux® series
Ultraflux® filters contain a Fresenius Polysulfone®
membrane specifically developed for continuous
renal replacement therapy. Successful treatments
are achieved by:
• Filter characteristics similar to those of the human
kidney’s glomeruli
Haemofilters
Type Description Units per box Art. No.
Ultraflux® AV 400 S Ultraflux® haemofilter, steam-sterilised, 0.75 m2 surface area, 12 500 734 1
Fresenius Polysulfone® membrane, blood priming volume 52 mL
Ultraflux® AV 600 S Ultraflux® haemofilter, steam-sterilised, 1.4 m2 surface area, 12 500 736 1
Fresenius Polysulfone® membrane, blood priming volume 100 mL
Ultraflux® AV 1000 S Ultraflux® haemofilter, steam-sterilised, 1.8 m2 surface area, 12 500 898 1
Fresenius Polysulfone® membrane, blood priming volume 130 mL
Ultraflux® AV paed Ultraflux® haemofilter, steam-sterilised, 0.2 m2 surface area, 20 500 823 1
Fresenius Polysulfone® membrane, blood priming volume 18 mL
Luer-Lock Dialysate & Filtrate ports
Ultraflux® AV paed must only be used with the dialyser holder for small dialysers (Art. No. M38 420 1)
• Retention of plasma proteins such as albumin, clotting
factors, immunglobulins and cellular blood constituents
• Excellent filter lifetimes
• Easy handling
• High biocompatibility
• Mechanical stability
• Filter size selectable to meet patient’s requirements
13Technical changes reserved Product Range – 01. 2010
PlasmafiltersplasmaFlux® series
The hollow fibres of the plasmaFlux® series sepa-
rate cell-free plasma from whole blood in order to
treat patients by plasma exchange or other plasma
therapies. Requirements for successful treatments
are fulfilled by the plasmaFlux® filter characteristics:
Plasmafilters
Type Description Units per box Art. No.
plasmaFlux PSu 1S Plasmafilter pre-filled with sterile water, steam-sterilised, 0.3 m2 surface area, 10 500 491 1
blood priming volume 36 mL, Fresenius Plasmasulfone membrane
plasmaFlux PSu 2S Plasmafilter pre-filled with sterile water, steam-sterilised, 0.6 m2 surface area, 10 500 481 1
blood priming volume 70 mL, Fresenius Plasmasulfone membrane
• Efficient extraction of pathogenic factors
• High biocompatibility
• Easy handling
• Long filter lifetimes
• Low extracellular volume
• Minimum requirement for anticoagulation therapy
Inline steam sterilisation
Filters of the Ultraflux® and plasmaFlux® series are 100% leakage checked and steam-
sterilized to offer a safe product that is free of any residues from the sterilization process.
14 Product Range – 01. 2010 Technical changes reserved
SolutionsmultiBic® – bicarbonate-buffered haemofiltration solutions
Larger, quieter, more convenient:When time is of the essence, every convenience helps.
For example, the new multiBic® double chamber bag
with diagonal peel-seam for simpler handling. Thanks
to 11% more content, the new 5 litre multiBic® doesn’t
need to be changed so often – leaving more time for
other tasks. The improved gas barrier helps to keep the
ready-to-use bicarbonate solution stable for longer so
that the infusion of the patient can last up to 48 hours.
The new 5 litre multiBic® at a glance:
• Mixing the two components provides 100% bicarbonate-buffered haemofiltration solution
• Always the right solution thanks to 4 different potassium concentrations
• Fewer bag changes thanks to 11% more content
• Increased solution stability, usable for up to 48 hrs. thanks to the improved gas barrier
• Simpler handling thanks to the bag geometry with diagonal peel-seam
• PVC, latex and DEHP-free, environmentally friendly thanks to use of “Biofine” material
• Quieter thanks to the packaging’s softer, sound-reduced foil
• Improved monitoring through the clear, transparent foil
• Easier transport thanks to the new, comfortable handle
• Suitable for almost all common CRRT appliances thanks to the bag eyelets and connectors
• Addition of medication possible thanks to the injection port
15Technical changes reserved Product Range – 01. 2010
Excipients: Water for injections, hydrochloric acid (25%), carbon dioxide
Indications: For use in patients with acute renal failure requiring continuous haemofiltration.
Contraindications: Solution dependent contraindications:
multiBic® potassium-free/2/3 mmol/L potassium:– hypokalaemia – metabolic alkalosis
multiBic® 4 mmol/L potassium:– hyperkalaemia – metabolic alkalosis
Haemofiltration dependent contraindications due to the technical procedure itself: – Renal failure with increased hypercatabolism in cases where uraemic symp-
toms can no longer be relieved by haemofiltration.– Inadequate blood flow from vascular access.– If there is a high risk of haemorrhage on account of systemic anticoagulation.
Side effects: Adverse reactions, such as nausea, vomiting, muscle cramps, hypotension and hypertension, may result from the treatment mode itself or may be induced by the substitution solution.
In general, the tolerability of bicarbonate buffered haemofiltration solution is good. However, the following potential side effects of the treatment can be anticipated:
Hyper- or hypohydration, electrolyte disturbances (e. g. hypokalaemia), hypo-phosphataemia, hyperglycaemia, and metabolic alkalosis.
Warnings and Precautions: Do not use unless solution is clear and the container is undamaged. Do not use before the two solutions have been mixed. The ready-to-use solution must be used within 48 hours after mixing. Any unused residual solution should be discarded. Do not store below +4°C.
Date: November 2009Fresenius Medical Care Deutschland GmbH 61346 Bad Homburg v.d.H., Germany
multiBic® potassium-free, Solution for HaemofiltrationmultiBic® 2 mmol/L potassium, Solution for HaemofiltrationmultiBic® 3 mmol/L potassium, Solution for HaemofiltrationmultiBic® 4 mmol/L potassium, Solution for Haemofiltration
multiBic® potassium-free/2/3/4 mmol/L potassium is delivered in a double-chamber bag. One chamber (large compartment) contains the alkaline hydrogen carbonate solution, the other chamber (small compartment) contains the acidic glucose-based electrolyte solution. Mixing of both solutions by opening the peel-seam between the two chambers results in the ready-to-use solution.
Composition: 1000 mL of the ready-to-use solution contain in mmol/L
Name Theoret. Na+ K+ Ca++ Mg++ CI– HCO3
– Glucose Osmol.multiBic® mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mosm/L
potassium-free 140 – 1.5 0.50 109 35 5.55 292
2 mmol/L potassium 140 2.0 1.5 0.50 111 35 5.55 296
3 mmol/L potassium 140 3.0 1.5 0.50 112 35 5.55 298
4 mmol/L potassium 140 4.0 1.5 0.50 113 35 5.55 300
pH 7.40 Availability depending on pharmaceutical product registration.
Composition: 1000 mL of the ready-to-use solution contain in g/L
Name Sodium Calcium Magnesium Glucose Sodium Potassium hydrogen chloride chloride mono- EquivalentmultiBic® chloride chloride carbonate dihydrate hexahydrate hydrate to glucose
potassium-free 6.136 – 2.940 0.2205 0.1017 1.100 1.000
2 mmol/L potassium 6.136 0.1491 2.940 0.2205 0.1017 1.100 1.000
3 mmol/L potassium 6.136 0.2237 2.940 0.2205 0.1017 1.100 1.000
4 mmol/L potassium 6.136 0.2982 2.940 0.2205 0.1017 1.100 1.000
Order information Language/Art. No.
Name D/NL/F/I GB/P/S/FIN E/TR/CZ/HU EST/LV/SK GB/HR/BiH RUS/UA DK/N PL/LT SLO/GR RO multiBic® 2 × 5 L 2 × 5 L 2 × 5 L 2 × 5 L 2 × 5 L 2 × 5 L
potassium-free 967 820 1 F00 001 138 F00 001 142 F00 001 146 F00 001 134 F00 001 300
2 mmol/L potassium 967 920 1 F00 001 139 F00 001 143 F00 001 147 F00 001 135 F00 001 301
3 mmol/L potassium 967 220 1 F00 001 140 F00 001 144 F00 001 148 F00 001 136 F00 001 302
4 mmol/L potassium 967 320 1 F00 001 141 F00 001 145 F00 001 149 F00 001 137 F00 001 303
Packaging: 5 litre bag, 2 bags per box, 104 bags per pallet
16 Product Range – 01. 2010 Technical changes reserved
SolutionsCi-Ca Solutions
Citrate anticoagulation for CRRT – A beneficial system:
• clearly reduced risk of bleeding
• prolonged filter life-spans
• Successful treatments of patients with HIT II
The advantage of the Ci-Ca method is that it acts exclu-
sively in the extracorporeal circuit making this method
specifically attractive for intensive care patients and
patients at risk of bleeding.
Ci-Ca Dialysate K2 and Ci-Ca Dialysate K4
The major role in regional citrate anticoagulation is
assigned to the calcium-free Ci-Ca Dialysate.
• two different potassium concentrations allow the
adaption to the patient´s requirements
• 5 L double chamber bag for safe and convenient
handling
• use of the mixed solutions for up to 48 h
17Technical changes reserved Product Range – 01. 2010
Article Art. no. Composition of the solution
Citrate mmol/L
4% Na3 citrate E2011 136
Packaging: 1 litre bag, 7 bags/box pH adjustment with citric acid
Article Art. no. Composition of the solution
Na+ K+ Ca++ Mg++ Cl– HCO3– Glucose
mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L g/L
Ci-Ca Dialysate K2 968 920 1 133 2.0 0 0.75 116.5 20 1.0
Ci-Ca Dialysate K4 F00 000 431 133 4.0 0 0.75 118.5 20 1.0
Packaging: 5 litre bag Other constituents: water for injections, hydrochloric acid 25%, carbon dioxide
2 bags per box
Ci-Ca Dialysate
Sodium Citrate 4%
Citrate solution for Ci-Ca therapy
The citrate solution refrains coagulation by forming
chelate complexes with the ionised calcium in blood.
• 4% citrate solution and Ci-Ca Dialysate are adapt-
ed to each other
• The citrate bag is equipped with a special
connector to avoid misconnections
Saline solutions
Type Art. no. Presentation Units per box Units per pallet
Isotonic saline solutions 0.9% 131 067 1 30 × 250 mL 1,440 units
(1 litre contains sodium chloride 9.0 g, 131 865 1 15 × 500 mL 720 units
Na+ 154 mmol/L, CI– 154 mmol/L) 131 866 1 10 × 1000 mL 480 units
If products are categorised as pharmaceuticals, availability depending on pharmaceutical product registration.
Sodium Citrate 4%
18 Product Range – 01. 2010 Technical changes reserved
SolutionsmultiPlus – The solution with physiological phosphate level
multiPlus
multiPlus (containing 1 mmol/L phosphate) prevents
the depletion of phosphate during CRRT.
• multiPlus prevents the development of hypophos-
phatemia
• Phosphate und glucose ensure the adequate provi-
sion of energy rich components for metabolic proc-
esses and may support the weaning from mechani-
cal ventilation.
Article Art. No. Composition of the solution:
Na+ K+ Ca++ Mg++ Cl– HCO3– Inorganic Phosphate Glucose
mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L g/L
multiPlus 968 820 1 140 2.0 1.5 0.75 109.7 35 1.0 1.0
Packaging: 5 litre bag, Other constituents: water for injection, hydrochloric acid 25%, carbon dioxide
2 bags per box
19Technical changes reserved Product Range – 01. 2010
Indications:1. End stage chronic renal disease (decompensation) of all origins2. Acute renal failure not accompanied by hypercatabolism3. Cardiac insufficiency not easily influenced by medicaments and caused by
hyperhydratation4. Acute states of intoxication caused by non-protein-bound poisons; use either
alone or in conjunction with other detoxication measures (haemodialysis, peritoneal dialysis and/or haemoperfusion)
5. Metabolic disturbance resulting from end stage chronic renal failure
Contraindications:Contraindications caused by the treatment:1. Acute renal failure accompanied by marked hypercatabolic conditions in cases
where uraemic symptoms can no longer be relieved by haemofiltration2. Insufficient blood flow from the shunt3. Recent cerebral or internal (parenchymatous) haemorrhages
Contraindications caused by the solution:HF 11: 1. Hypokalaemia 2. Impairment of lactate metabolism/lactate acidosis
HF 12, HF 23, HF 24: 1. Hypokalaemia 2. Hypercalcemia 3. Impairment of lactate metabolism/lactate acidosis
Note:HF 11, HF 12, HF 23: In cases of marked hyperhydration and marked dehydration (high ultrafiltra-tion), it is advisable to use a solution with a higher sodium content, taking into account the serum sodium concentration of the patient.
HF 11, 12: In diabetic patients receiving insulin, the dose of insulin should be adjusted as appropriate for the glucose content of the haemofiltration solution.
Side effects:None have been observed up to the present.
Warnings and precautions:Do not store above +25°C. Do not use unless solution is clear and the con-tainer is undamaged.
Date: November 2009 Fresenius Medical Care Deutschland GmbH,61346 Bad Homburg v.d.H., Germany
Type/Art. No. Composition of the ready-to-use solution in mmol/L:
Name 2 × 2 × Na+ K+ Ca++ Mg++ CI– Lactate – Theoret. Osmol
4.5 L 5.0 L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mosm/L
HF 11 207 659 1 – 140 1 1.625 0.75 100.75 45 300
HF 12 – 207 720 1 140 1 1.875 0.75 100.75 45.5 301
HF 23 208 159 1 – 140 2 2.125 0.75 112.0 35.75 301
HF 24 208 259 1 – 142 2 2 0.75 105.0 44.5 296
Availability depending on pharmaceutical product registration.
Type/Art. No. Composition of the ready-to-use solution in g/L:
Name 2 × 2 × Sodium Calcium Magnesium Glucose
4.5 L 5.0 L Sodium lactate Sodium Potassium chloride chloride mono- Glucose
chloride solution lactate chloride • 2 H2O • 6 H2O hydrate (waterfree)
HF 11 207 659 1 – 5.552 10.09 5.045 0.0746 0.2389 0.1525 2.154 1.9581
HF 12 – 207 720 1 5.52 10.2 5.1 0.0746 0.2756 0.1525 2.154 1.96
HF 23 208 159 1 – 6.09 8.02 4.01 0.1492 0.3124 0.1525 1.65 1.5
HF 24 208 259 1 – 5.698 9.98 4.99 0.1492 0.294 0.1525 – –
Number of units per pallet: 112 Other constituents: water for injections, hydrochloric acid, sodium hydroxide
56 boxes, each containing two bags.
SolutionsLactate-buffered haemofiltration solutions
20 Product Range – 01. 2010 Technical changes reserved
Temporary dialysis catheters
High flow double lumen catheter
• Double lumen shaft geometry in combination
with large inlet and outlet ports at the catheter tip
ensure a low flow resistance also at high blood
flows
• Soft catheter tip – minimises the risk of vascular
lesions upon catheter placement
• Excellent kinking stability
• Optimal range of application: blood flows between
150 mL/min and 400 mL/min
Standard double lumen catheter
• Contralaterally arranged inlet and outlet ports
reduce recirculation
• Optimal range of application: blood flows up to
200 mL/min
• Soft catheter tip – minimises the risk of vascular
lesions upon catheter placement
High flow double lumen catheter sets*
Type Size and length Article No.
TH1415 14.5 F × 150 mm 507 780 1
TH1417 14.5 F × 175 mm 507 782 1
TH1420 14.5 F × 200 mm 507 783 1
TH1424 14.5 F × 240 mm 507 784 1
Double lumen catheter sets*
Type Size and length Article No.
TD1115 11 F × 150 mm 502 877 1
TD1117 11 F × 175 mm 502 874 1
TD1120 11 F × 200 mm 502 878 1
Fresenius Medical Care has developed temporary dialy-
sis catheters specifically for the use in acute therapies.
They ensure a rapid and safe central venous vascular
access via the jugular, subclavian or femoral vein.
* Included accessories: Seldinger puncture cannula (17 G × 70 mm), guide wire (0.95 × 700 mm), step dilatator, injection closure caps, CathClip
21Technical changes reserved Product Range – 01. 2010
Disposables and accessories
Waste bags
Type Description Connection Units per box Art. No.
Waste bag 2000 mL Waste bag with female Luer-Lock connector 100 501 509 1
PF waste bag 5000 mL Waste bag with male Luer-Lock connector for single use 50 501 510 1
Filtrate bag 10 L Filtrate collection bag with draining cock, 40 502 901 1
male Luer-Lock connector
Filtrate bag 10 L Filtrate collection bag with male Luer-Lock, 40 502 903 1
Single use single use
Accessories
Type Description Connection Units per box Art. No.
Scissor clamp For clamping lines 5 284 024 1
Freka-Flex Infusion set Infusion set with roller clamp and drip 150 288 901 1
chamber male Luer-lock
Pressure monitor line Pressure monitor line with filter, 100 501 463 1
connector female/male Luer-Lock, length 30 cm
PF-Adapter HF female/ Connection of infusion sets to HF tubing 100 501 474 1
Luer-Lock female
Adapter Connector 2 male Luer-Lock 100 501 477 1
Luer-Lock male
Adapter Connector 2 female Luer-Lock 100 501 480 1
Luer-Lock female
Filtrate adapter Luer-Lock female CVVH/D adapter 100 501 491 1
to the filtrate outlet of a dialyser
Transducer Protector Pressure filter, connector male/female Luer-Lock 100 501 591 1
Spike female Luer-Lock/Spike 100 501 592 1
Vented Spike female Luer-Lock/Spike (vented) 100 F0000520
HF female/ Connection of bags with septum to 100 501 635 1
spike adapter HF tubing system
Adapter HF female/ Connection of 100 501 689 1
Luer-Lock male rinsing solution to HF tubing
Pressure measurement Pressure monitor line with filter, 200 501 915 1
line 60 cm connector male/female Luer-Lock, length 60 cm,
for arterial pressure measurement
SN-adapter Y-adapter, 100 502 785 1
2 × female Luer-Lock/1 × male Luer-Lock
Adapter 2 × HF female / To connect 4 HF bags to HF tubings 30 504 613 1
4 × HF male
Adapter Luer-Lock female/ To connect 6 HF solutions to a substituate 30 504 602 1
6 × HF male (FSG102) system
Check valve Check valve male Luer-Lock/ 100 850 280 2
female Luer-Lock
Heparin syringe 50 mL Fresenius Injectomat syringe, latex-free, male Luer-Lock 100 900 071 1
Heparin syringe 50 mL Fresenius P-syringe, latex-free, male Luer-Lock 100 900 076 1
22 Product Range – 01. 2010 Technical changes reserved
Order list
Hospital/Dept.
Title/Name
Street
Country/Postal code/City
Customer No.
Art. No. Article Amount Price
23Technical changes reserved Product Range – 01. 2010
Headoffice: FreseniusMedicalCareDeutschlandGmbH·61346BadHomburgv.d.H.·Germany·Phone:+49(0)6172-609-0·Fax:+49(0)6172-609-2191
www.fmc-ag.com
732
656
1/8
GB
(1 P
UR
-xx
01.1
0)
© C
opyr
ight
201
0 Fr
esen
ius
Med
ical
Car
e D
euts
chla
nd G
mbH
· T
echn
ical
cha
nges
rese
rved